Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patent Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Patent Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Patent Drug Market Perspective (2018-2029)
2.2 Patent Drug Growth Trends by Region
2.2.1 Global Patent Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Patent Drug Historic Market Size by Region (2018-2024)
2.2.3 Patent Drug Forecasted Market Size by Region (2024-2029)
2.3 Patent Drug Market Dynamics
2.3.1 Patent Drug Industry Trends
2.3.2 Patent Drug Market Drivers
2.3.3 Patent Drug Market Challenges
2.3.4 Patent Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patent Drug Players by Revenue
3.1.1 Global Top Patent Drug Players by Revenue (2018-2024)
3.1.2 Global Patent Drug Revenue Market Share by Players (2018-2024)
3.2 Global Patent Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Patent Drug Revenue
3.4 Global Patent Drug Market Concentration Ratio
3.4.1 Global Patent Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patent Drug Revenue in 2022
3.5 Patent Drug Key Players Head office and Area Served
3.6 Key Players Patent Drug Product Solution and Service
3.7 Date of Enter into Patent Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Patent Drug Breakdown Data by Type
4.1 Global Patent Drug Historic Market Size by Type (2018-2024)
4.2 Global Patent Drug Forecasted Market Size by Type (2024-2029)
5 Patent Drug Breakdown Data by Application
5.1 Global Patent Drug Historic Market Size by Application (2018-2024)
5.2 Global Patent Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Patent Drug Market Size (2018-2029)
6.2 North America Patent Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Patent Drug Market Size by Country (2018-2024)
6.4 North America Patent Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Patent Drug Market Size (2018-2029)
7.2 Europe Patent Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Patent Drug Market Size by Country (2018-2024)
7.4 Europe Patent Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Patent Drug Market Size (2018-2029)
8.2 Asia-Pacific Patent Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Patent Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Patent Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Patent Drug Market Size (2018-2029)
9.2 Latin America Patent Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Patent Drug Market Size by Country (2018-2024)
9.4 Latin America Patent Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patent Drug Market Size (2018-2029)
10.2 Middle East & Africa Patent Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Patent Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Patent Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Patent Drug Introduction
11.1.4 Pfizer Revenue in Patent Drug Business (2018-2024)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Patent Drug Introduction
11.2.4 Roche Revenue in Patent Drug Business (2018-2024)
11.2.5 Roche Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Patent Drug Introduction
11.3.4 Sanofi Revenue in Patent Drug Business (2018-2024)
11.3.5 Sanofi Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Patent Drug Introduction
11.4.4 Johnson & Johnson Revenue in Patent Drug Business (2018-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Detail
11.5.2 Merck & Co. (MSD) Business Overview
11.5.3 Merck & Co. (MSD) Patent Drug Introduction
11.5.4 Merck & Co. (MSD) Revenue in Patent Drug Business (2018-2024)
11.5.5 Merck & Co. (MSD) Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Patent Drug Introduction
11.6.4 Novartis Revenue in Patent Drug Business (2018-2024)
11.6.5 Novartis Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Patent Drug Introduction
11.7.4 AbbVie Revenue in Patent Drug Business (2018-2024)
11.7.5 AbbVie Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Patent Drug Introduction
11.8.4 Gilead Sciences Revenue in Patent Drug Business (2018-2024)
11.8.5 Gilead Sciences Recent Development
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Detail
11.9.2 GlaxoSmithKline (GSK) Business Overview
11.9.3 GlaxoSmithKline (GSK) Patent Drug Introduction
11.9.4 GlaxoSmithKline (GSK) Revenue in Patent Drug Business (2018-2024)
11.9.5 GlaxoSmithKline (GSK) Recent Development
11.10 Amgen
11.10.1 Amgen Company Detail
11.10.2 Amgen Business Overview
11.10.3 Amgen Patent Drug Introduction
11.10.4 Amgen Revenue in Patent Drug Business (2018-2024)
11.10.5 Amgen Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Patent Drug Introduction
11.11.4 AstraZeneca Revenue in Patent Drug Business (2018-2024)
11.11.5 AstraZeneca Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Detail
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Patent Drug Introduction
11.12.4 Bristol-Myers Squibb Revenue in Patent Drug Business (2018-2024)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Detail
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Patent Drug Introduction
11.13.4 Eli Lilly Revenue in Patent Drug Business (2018-2024)
11.13.5 Eli Lilly Recent Development
11.14 Teva
11.14.1 Teva Company Detail
11.14.2 Teva Business Overview
11.14.3 Teva Patent Drug Introduction
11.14.4 Teva Revenue in Patent Drug Business (2018-2024)
11.14.5 Teva Recent Development
11.15 Bayer
11.15.1 Bayer Company Detail
11.15.2 Bayer Business Overview
11.15.3 Bayer Patent Drug Introduction
11.15.4 Bayer Revenue in Patent Drug Business (2018-2024)
11.15.5 Bayer Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Detail
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Patent Drug Introduction
11.16.4 Novo Nordisk Revenue in Patent Drug Business (2018-2024)
11.16.5 Novo Nordisk Recent Development
11.17 AbbVie
11.17.1 AbbVie Company Detail
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Patent Drug Introduction
11.17.4 AbbVie Revenue in Patent Drug Business (2018-2024)
11.17.5 AbbVie Recent Development
11.18 Takeda
11.18.1 Takeda Company Detail
11.18.2 Takeda Business Overview
11.18.3 Takeda Patent Drug Introduction
11.18.4 Takeda Revenue in Patent Drug Business (2018-2024)
11.18.5 Takeda Recent Development
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Detail
11.19.2 Boehringer Ingelheim Business Overview
11.19.3 Boehringer Ingelheim Patent Drug Introduction
11.19.4 Boehringer Ingelheim Revenue in Patent Drug Business (2018-2024)
11.19.5 Boehringer Ingelheim Recent Development
11.20 Takeda
11.20.1 Takeda Company Detail
11.20.2 Takeda Business Overview
11.20.3 Takeda Patent Drug Introduction
11.20.4 Takeda Revenue in Patent Drug Business (2018-2024)
11.20.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Patent Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Key Players of Other
Table 5. Global Patent Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Patent Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Patent Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Patent Drug Market Share by Region (2018-2024)
Table 9. Global Patent Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Patent Drug Market Share by Region (2024-2029)
Table 11. Patent Drug Market Trends
Table 12. Patent Drug Market Drivers
Table 13. Patent Drug Market Challenges
Table 14. Patent Drug Market Restraints
Table 15. Global Patent Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Patent Drug Market Share by Players (2018-2024)
Table 17. Global Top Patent Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Drug as of 2022)
Table 18. Ranking of Global Top Patent Drug Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Patent Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Patent Drug Product Solution and Service
Table 22. Date of Enter into Patent Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Patent Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Patent Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Patent Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Patent Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Patent Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Patent Drug Revenue Market Share by Application (2018-2024)
Table 30. Global Patent Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Patent Drug Revenue Market Share by Application (2024-2029)
Table 32. North America Patent Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Patent Drug Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Patent Drug Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Patent Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Patent Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Patent Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Patent Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Patent Drug Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Patent Drug Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Patent Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Patent Drug Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Patent Drug Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Patent Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Patent Drug Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Patent Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Pfizer Company Detail
Table 48. Pfizer Business Overview
Table 49. Pfizer Patent Drug Product
Table 50. Pfizer Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Roche Company Detail
Table 53. Roche Business Overview
Table 54. Roche Patent Drug Product
Table 55. Roche Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 56. Roche Recent Development
Table 57. Sanofi Company Detail
Table 58. Sanofi Business Overview
Table 59. Sanofi Patent Drug Product
Table 60. Sanofi Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 61. Sanofi Recent Development
Table 62. Johnson & Johnson Company Detail
Table 63. Johnson & Johnson Business Overview
Table 64. Johnson & Johnson Patent Drug Product
Table 65. Johnson & Johnson Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 66. Johnson & Johnson Recent Development
Table 67. Merck & Co. (MSD) Company Detail
Table 68. Merck & Co. (MSD) Business Overview
Table 69. Merck & Co. (MSD) Patent Drug Product
Table 70. Merck & Co. (MSD) Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 71. Merck & Co. (MSD) Recent Development
Table 72. Novartis Company Detail
Table 73. Novartis Business Overview
Table 74. Novartis Patent Drug Product
Table 75. Novartis Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. AbbVie Company Detail
Table 78. AbbVie Business Overview
Table 79. AbbVie Patent Drug Product
Table 80. AbbVie Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 81. AbbVie Recent Development
Table 82. Gilead Sciences Company Detail
Table 83. Gilead Sciences Business Overview
Table 84. Gilead Sciences Patent Drug Product
Table 85. Gilead Sciences Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 86. Gilead Sciences Recent Development
Table 87. GlaxoSmithKline (GSK) Company Detail
Table 88. GlaxoSmithKline (GSK) Business Overview
Table 89. GlaxoSmithKline (GSK) Patent Drug Product
Table 90. GlaxoSmithKline (GSK) Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 91. GlaxoSmithKline (GSK) Recent Development
Table 92. Amgen Company Detail
Table 93. Amgen Business Overview
Table 94. Amgen Patent Drug Product
Table 95. Amgen Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 96. Amgen Recent Development
Table 97. AstraZeneca Company Detail
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Patent Drug Product
Table 100. AstraZeneca Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 101. AstraZeneca Recent Development
Table 102. Bristol-Myers Squibb Company Detail
Table 103. Bristol-Myers Squibb Business Overview
Table 104. Bristol-Myers Squibb Patent Drug Product
Table 105. Bristol-Myers Squibb Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 106. Bristol-Myers Squibb Recent Development
Table 107. Eli Lilly Company Detail
Table 108. Eli Lilly Business Overview
Table 109. Eli Lilly Patent Drug Product
Table 110. Eli Lilly Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 111. Eli Lilly Recent Development
Table 112. Teva Company Detail
Table 113. Teva Business Overview
Table 114. Teva Patent Drug Product
Table 115. Teva Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 116. Teva Recent Development
Table 117. Bayer Company Detail
Table 118. Bayer Business Overview
Table 119. Bayer Patent Drug Product
Table 120. Bayer Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 121. Bayer Recent Development
Table 122. Novo Nordisk Company Detail
Table 123. Novo Nordisk Business Overview
Table 124. Novo Nordisk Patent Drug Product
Table 125. Novo Nordisk Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 126. Novo Nordisk Recent Development
Table 127. AbbVie Company Detail
Table 128. AbbVie Business Overview
Table 129. AbbVie Patent Drug Product
Table 130. AbbVie Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 131. AbbVie Recent Development
Table 132. Takeda Company Detail
Table 133. Takeda Business Overview
Table 134. Takeda Patent Drug Product
Table 135. Takeda Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 136. Takeda Recent Development
Table 137. Boehringer Ingelheim Company Detail
Table 138. Boehringer Ingelheim Business Overview
Table 139. Boehringer Ingelheim Patent Drug Product
Table 140. Boehringer Ingelheim Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 141. Boehringer Ingelheim Recent Development
Table 142. Takeda Company Detail
Table 143. Takeda Business Overview
Table 144. Takeda Patent Drug Product
Table 145. Takeda Revenue in Patent Drug Business (2018-2024) & (US$ Million)
Table 146. Takeda Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Patent Drug Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Patent Drug Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Other Features
Figure 6. Global Patent Drug Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 7. Global Patent Drug Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Patent Drug Report Years Considered
Figure 11. Global Patent Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Patent Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Patent Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Patent Drug Market Share by Players in 2022
Figure 15. Global Top Patent Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Patent Drug Revenue in 2022
Figure 17. North America Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Patent Drug Market Share by Country (2018-2029)
Figure 19. United States Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Patent Drug Market Share by Country (2018-2029)
Figure 23. Germany Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Patent Drug Market Share by Region (2018-2029)
Figure 31. China Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Patent Drug Market Share by Country (2018-2029)
Figure 39. Mexico Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Patent Drug Market Share by Country (2018-2029)
Figure 43. Turkey Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Patent Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Pfizer Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 46. Roche Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 47. Sanofi Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 48. Johnson & Johnson Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 49. Merck & Co. (MSD) Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 50. Novartis Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 51. AbbVie Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 52. Gilead Sciences Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 53. GlaxoSmithKline (GSK) Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 54. Amgen Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 55. AstraZeneca Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 57. Eli Lilly Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 58. Teva Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 59. Bayer Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 60. Novo Nordisk Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 61. AbbVie Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 62. Takeda Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 64. Takeda Revenue Growth Rate in Patent Drug Business (2018-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed